GlassScriptPhysician profile
Farhana Rahman
NPI 1033484266
$1,011.11
in general payments reported to CMS, 2019-2025
19 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.64 · 2020: $109 · 2022: $16.33 · 2023: $177 · 2024: $451 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $131.19 | 2023-2025 | |
| Nabriva Therapeutics, Plc | $109.06 | 2020 | |
| Novo Nordisk INC | $87.15 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $87.10 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $78.96 | 2024-2025 | Airsupra, Farxiga |
| Amgen INC. | $75.12 | 2024-2025 | Repatha, Otezla, Repatha |
| Inspire Medical Systems, INC. | $66.19 | 2024 | Inspire |
| Medtronic, INC. | $56.45 | 2023-2024 | Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $54.46 | 2025 | |
| Abbvie INC. | $42.09 | 2024 | |
| Lilly USA, LLC | $39.01 | 2023-2024 | Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.81 | 2024 | Xifaxan |
| Cipher Pharmaceuticals US LLC | $28.96 | 2025 | Natroba, Spinosad |
| Si-Bone, INC. | $23.52 | 2024 | |
| Corcept Therapeutics | $23.28 | 2024 | Korlym |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $21.10 | 2024 | Immunocap |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.64 | 2019 | |
| Ardelyx, INC. | $18.69 | 2023 | Ibsrela |
| Janssen Pharmaceuticals, INC | $16.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhana Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.